Photo not available

Craig T. Jordan, Ph.D.

Contact Information

University of Colorado School of Medicine
Division of Hematology, 12700 E. 19th Avenue
Campus Box F754-AMCA
Aurora, CO 80045

Office: (585) 275-6339
Lab: (585) 273-1394
Administrative: (585) 275-1537
Fax: (585) 276-2596

Journal Articles

Showing all 92 journal articles available.

2013 Aug 15
Sampson ER, McMurray HR, Hassane DC, Newman L, Salzman P, Jordan CT, Land H. "Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery." Oncogene.. 2013 Aug 15; 32(33):3809-18. Epub 2012 Sep 10.
2013 Mar 7
Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O'Dwyer KM, Liesveld JL, Brookes PS, Becker MW, Jordan CT. "BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells." Cell stem cell.. 2013 Mar 7; 12(3):329-41. Epub 2013 Jan 17.
2013
Nielsen TH, Johnson N, Garnier N, Kwan S, Yao L, Cocolakis E, Hébert J, Morgan RA, Paquet E, Callahan KP, Jordan CT, Assouline S, Miller WH, Mann KK. "Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient." Frontiers in pharmacology. 2013 4:9. Epub 2013 Feb 12.
2012 Sep 7
Ashton JM, Balys M, Neering SJ, Hassane DC, Cowley G, Root DE, Miller PG, Ebert BL, McMurray HR, Land H, Jordan CT. "Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells." Cell stem cell.. 2012 Sep 7; 11(3):359-72. Epub 2012 Aug 02.
2012 Apr
Zhao C, Xiu Y, Ashton J, Xing L, Morita Y, Jordan CT, Boyce BF. "Noncanonical NF-?B signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions." Stem cells.. 2012 Apr; 30(4):709-18.
2012 Jan 12
Frisch BJ, Ashton JM, Xing L, Becker MW, Jordan CT, Calvi LM. "Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia." Blood.. 2012 Jan 12; 119(2):540-50. Epub 2011 Sep 28.
2012
Pei S, Jordan CT. "How close are we to targeting the leukemia stem cell?" Best practice & research. Clinical haematology.. 2012 25(4):415-8. Epub 2012 Oct 23.
2011 Sep 2
Becker MW, Jordan CT. "Leukemia stemness signatures step toward the clinic." Cell stem cell.. 2011 Sep 2; 9(3):185-6.
2011 Aug 15
Nasim S, Guzman ML, Jordan CT, Crooks PA. "Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture." Bioorganic & medicinal chemistry letters.. 2011 Aug 15; 21(16):4879-83. Epub 2011 Jun 22.
2011 Aug
Liesveld JL, Rosell KE, Bechelli J, Lu C, Messina P, Mulford D, Ifthikharuddin JJ, Jordan CT, Phillips Ii GL. "Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines." Cancer investigation. 2011 Aug; 29(7):439-50.
2011 Mar
Becker MW, Jordan CT. "Leukemia stem cells in 2010: current understanding and future directions." Blood reviews. 2011 Mar; 25(2):75-81. Epub 2011 Jan 08.
2011 Feb 15
Nasim S, Pei S, Hagen FK, Jordan CT, Crooks PA. "Melampomagnolide B: a new antileukemic sesquiterpene." Bioorganic & medicinal chemistry.. 2011 Feb 15; 19(4):1515-9. Epub 2011 Jan 06.
2011 Feb 10
Konopleva MY, Jordan CT. "Leukemia stem cells and microenvironment: biology and therapeutic targeting." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2011 Feb 10; 29(5):591-9. Epub 2011 Jan 10.
2011
Benito J, Shi Y, Szymanska B, Carol H, Boehm I, Lu H, Konoplev S, Fang W, Zweidler-McKay PA, Campana D, Borthakur G, Bueso-Ramos C, Shpall E, Thomas DA, Jordan CT, Kantarjian H, Wilson WR, Lock R, Andreeff M, Konopleva M. "Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104." PloS one. 2011 6(8):e23108. Epub 2011 Aug 11.
2010 Oct
Dai Y, Guzman ML, Chen S, Wang L, Yeung SK, Pei XY, Dent P, Jordan CT, Grant S. "The NF (Nuclear factor)-?B inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells." British journal of haematology.. 2010 Oct; 151(1):70-83. Epub 2010 Aug 02.
2010 Sep 15
Silvers CR, Williams K, Salamone L, Huang J, Jordan CT, Zhou H, Palapattu GS. "A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors." The Prostate.. 2010 Sep 15; 70(13):1379-87.
2010 Aug 5
Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim SH, Kim DW, Chuah C, Oehler VG, Radich JP, Jordan CT, Reya T. "Regulation of myeloid leukaemia by the cell-fate determinant Musashi." Nature.. 2010 Aug 5; 466(7307):765-8. Epub 2010 Jul 18.
2010 Jun
Cairo MS, Jordan CT, Maley CC, Chao C, Melnick A, Armstrong SA, Shlomchik W, Molldrem J, Ferrone S, Tycko B, Mackall C, Zitvogel L, Bishop MR, Giralt SA, June CH. "NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2010 Jun; 16(6):709-28. Epub 2010 Mar 12.
2010 May 12
Jordan CT. "Targeting myeloid leukemia stem cells." Science translational medicine. 2010 May 12; 2(31):31ps21.
2010
Hassane DC, Sen S, Minhajuddin M, Rossi RM, Corbett CA, Balys M, Wei L, Crooks PA, Guzman ML, Jordan CT. "Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways." Blood.. 2010 116(26):5983-90. Epub 2010 Oct 01.
2009 Nov 5
Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, O'Keefe RJ, Jordan CT, Calvi LM. "In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells." Blood.. 2009 Nov 5; 114(19):4054-63. Epub 2009 Sep 02.
2009 Sep
Korver W, Zhao X, Singh S, Pardoux C, Zhao J, Guzman ML, Sen S, Yonkovich S, Liu S, Zhan X, Tomasevic N, Zhou C, Gros D, Jordan CT, Gotlib J, Hsi ED, Abo A. "Monoclonal antibodies against IREM-1: potential for targeted therapy of AML." Leukemia.. 2009 Sep; 23(9):1587-97. Epub 2009 May 14.
2009 Aug 1
Neelakantan S, Nasim S, Guzman ML, Jordan CT, Crooks PA. "Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1)." Bioorganic & medicinal chemistry letters.. 2009 Aug 1; 19(15):4346-9. Epub 2009 May 27.
2009 Aug 1
Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG, Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ, Dicker AP, Chen Y. "Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials." International journal of radiation oncology, biology, physics.. 2009 Aug 1; 74(5):1580-91. Epub 2009 Jun 17.
2009 Jun 26
Rosen JM, Jordan CT. "The increasing complexity of the cancer stem cell paradigm." Science.. 2009 Jun 26; 324(5935):1670-3.
2009 Apr 7
Guzman ML, Jordan CT. "Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biology." Cancer cell. 2009 Apr 7; 15(4):252-4.
2009 Mar 6
Jordan CT. "Cancer stem cells: controversial or just misunderstood?" Cell stem cell.. 2009 Mar 6; 4(3):203-5.
2009
Skalska J, Brookes PS, Nadtochiy SM, Hilchey SP, Jordan CT, Guzman ML, Maggirwar SB, Briehl MM, Bernstein SH. "Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide." PloS one. 2009 4(12):e8115. Epub 2009 Dec 02.
2008 Nov 15
Wang PY, Young F, Chen CY, Stevens BM, Neering SJ, Rossi RM, Bushnell T, Kuzin I, Heinrich D, Bottaro A, Jordan CT. "The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene." Blood.. 2008 Nov 15; 112(10):4184-92. Epub 2008 Aug 28.
2008 Oct
Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW. "Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology. 2008 Oct; 19(10):1759-64. Epub 2008 May 25.
2008 Jun 15
Hassane DC, Guzman ML, Corbett C, Li X, Abboud R, Young F, Liesveld JL, Carroll M, Jordan CT. "Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data." Blood.. 2008 Jun 15; 111(12):5654-62. Epub 2008 Feb 27.
2008 Jun
Young FM, Campbell A, Emo KL, Jansson J, Wang PY, Jordan CT, Mullen CA. "High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2008 Jun; 14(6):622-30. Epub 2008 Apr 14.
2008 May 1
Hewamana S, Alghazal S, Lin TT, Clement M, Jenkins C, Guzman ML, Jordan CT, Neelakantan S, Crooks PA, Burnett AK, Pratt G, Fegan C, Rowntree C, Brennan P, Pepper C. "The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target." Blood.. 2008 May 1; 111(9):4681-9. Epub 2008 Jan 28.
2008 Feb 1
Kim SW, Oleksyn DW, Rossi RM, Jordan CT, Sanz I, Chen L, Zhao J. "Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells." Blood.. 2008 Feb 1; 111(3):1644-53. Epub 2007 Nov 19.
2008 Feb
Mao G, Yuan F, Absher K, Jennings CD, Howard DS, Jordan CT, Gu L. "Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukemia: potential contribution to AML progression." Cell research.. 2008 Feb; 18(2):281-9.
2008
Hewamana S, Lin TT, Jenkins C, Burnett AK, Jordan CT, Fegan C, Brennan P, Rowntree C, Pepper C. "The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2008 14(24):8102-11.
2008
Jordan CT. "Can we finally target the leukemic stem cells?" Best practice & research. Clinical haematology.. 2008 21(4):615-20.
2007 Oct 1
Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY, Bell DR, Heinrich D, Bottaro A, Jordan CT. "Leukemia stem cells in a genetically defined murine model of blast-crisis CML." Blood.. 2007 Oct 1; 110(7):2578-85. Epub 2007 Jun 29.
2007 Mar
Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR. "Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice." Arteriosclerosis, thrombosis, and vascular biology.. 2007 Mar; 27(3):600-6. Epub 2007 Jan 04.
2007 Mar
Jordan CT. "The leukemic stem cell." Best practice & research. Clinical haematology.. 2007 Mar; 20(1):13-8.
2007
Guzman ML, Li X, Corbett CA, Rossi RM, Bushnell T, Liesveld JL, Hébert J, Young F, Jordan CT. "Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)." Blood.. 2007 110(13):4436-44. Epub 2007 Sep 04.
2007
Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, Carroll M, Liesveld JL, Crooks PA, Jordan CT. "An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells." Blood.. 2007 110(13):4427-35. Epub 2007 Sep 05.
2007
Guzman,M. L.; Li,X.; Corbett,C. A.; Rossi,R. M.; Bushnell,T.; Liesveld,J. L.; Hebert,J.; Young,F.; Jordan,C. T.;. "Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)". Blood. 2007; .
2007
Guzman,M. L.; Rossi,R. M.; Neelakantan,S.; Li,X.; Corbett,C. A.; Hassane,D. C.; Becker,M. W.; Bennett,J. M.; Sullivan,E.; Lachowicz,J. L.; Vaughan,A.; Sweeney,C. J.; Matthews,W.; Carroll,M.; Liesveld,J. L.; Crooks,P. A.; Jordan,C. T.;. "An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells". Blood. 2007; .
2006 Oct
Jordan CT. "Searching for leukemia stem cells--not yet the end of the road?" Cancer cell. 2006 Oct; 10(4):253-4.
2006 Sep 21
Jordan CT, Guzman ML, Noble M. "Cancer stem cells." The New England journal of medicine.. 2006 Sep 21; 355(12):1253-61.
2006 Sep
Weber JM, Forsythe SR, Christianson CA, Frisch BJ, Gigliotti BJ, Jordan CT, Milner LA, Guzman ML, Calvi LM. "Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells." Bone.. 2006 Sep; 39(3):485-93. Epub 2006 May 02.
2006
Weber,J. M.; Forsythe,S. R.; Christianson,C. A.; Frisch,B. J.; Gigliotti,B. J.; Jordan,C. T.; Milner,L. A.; Guzman,M. L.; Calvi,L. M.;. "Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells". Bone. 2006; . Link
2006
Klebanov L, Jordan C, Yakovlev A. "A new type of stochastic dependence revealed in gene expression data." Statistical applications in genetics and molecular biology. 2006 5:Article7. Epub 2006 Mar 06.
2005 Sep
Guzman ML, Jordan CT. "Feverfew: weeding out the root of leukaemia." Expert opinion on biological therapy.. 2005 Sep; 5(9):1147-52.
2005 Jun 1
Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT. "The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells." Blood.. 2005 Jun 1; 105(11):4163-9. Epub 2005 Feb 01.
2005 May
Jordan CT. "Targeting the most critical cells: approaching leukemia therapy as a problem in stem cell biology." Nature clinical practice. Oncology. 2005 May; 2(5):224-5.
2005 Apr
Jordan CT. "The potential of targeting malignant stem cells as a treatment for leukemia." Future oncology (London, England). 2005 Apr; 1(2):205-7.
2005 Feb
Topisirovic I, Kentsis A, Perez JM, Guzman ML, Jordan CT, Borden KL. "Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels." Molecular and cellular biology.. 2005 Feb; 25(3):1100-12.
2004 Nov
Jordan CT. "A new approach to treatment of acute myelogenous leukemia using targeted therapy in combination with standard chemotherapy." Leukemia research.. 2004 Nov; 28(11):1121-2.
2004 Sep 20
Jordan CT, Guzman ML. "Mechanisms controlling pathogenesis and survival of leukemic stem cells." Oncogene.. 2004 Sep 20; 23(43):7178-87.
2004 Aug 1
Goodrum F, Jordan CT, Terhune SS, High K, Shenk T. "Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations." Blood.. 2004 Aug 1; 104(3):687-95. Epub 2004 Apr 13.
2004
Guzman ML, Jordan CT. "Considerations for targeting malignant stem cells in leukemia." Cancer control : journal of the Moffitt Cancer Center.. 2004 11(2):97-104.
2004
Liesveld JL, Jordan CT, Phillips GL. "The hematopoietic stem cell in myelodysplasia." Stem cells.. 2004 22(4):590-9.
2004
Jordan CT. "Cancer stem cell biology: from leukemia to solid tumors." Current opinion in cell biology. 2004 16(6):708-12.
2004
Gilliland DG, Jordan CT, Felix CA. "The molecular basis of leukemia." Hematology. 2004 :80-97.
2003
Topisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering SJ, Jordan CT, Borden KL. "Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis." Molecular and cellular biology.. 2003 23(24):8992-9002.
2002 Oct
Gong S, Lu X, Xu Y, Swiderski CF, Jordan CT, Moscow JA. "Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias." Experimental hematology.. 2002 Oct; 30(10):1162-9.
2002 Apr
Jordan CT. "Unique molecular and cellular features of acute myelogenous leukemia stem cells." Leukemia.. 2002 Apr; 16(4):559-62.
2002
Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ, Jordan CT. "Preferential induction of apoptosis for primary human leukemic stem cells." Proceedings of the National Academy of Sciences of the United States of America.. 2002 99(25):16220-5. Epub 2002 Nov 25.
2002
Goodrum FD, Jordan CT, High K, Shenk T. "Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency." Proceedings of the National Academy of Sciences of the United States of America.. 2002 99(25):16255-60. Epub 2002 Nov 27.
2002
Srour EF, Jordan CT. "Isolation and characterization of primitive hematopoietic cells based on their position in the cell cycle." Methods in molecular medicine. 2002 63:93-111.
2001 Nov
Nolta JA, Jordan CT. "Spotlight on hematopoietic stem cells: looking beyond dogma. Introduction." Leukemia.. 2001 Nov; 15(11):1677-80.
2001 Oct 15
Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Jordan CT. "Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells." Blood.. 2001 Oct 15; 98(8):2301-7.
2001 Sep
Jordan CT, Vanin EF, Marini FC. "The use of adenoviral vectors for genetic manipulation and analysis of primitive hematopoietic cells." Current gene therapy. 2001 Sep; 1(3):257-65.
2001 Apr 1
Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL, Jordan CT. "Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells." Blood.. 2001 Apr 1; 97(7):2177-9.
2001 Jan
Lemischka IR, Jordan CT. "The return of clonal marking sheds new light on human hematopoietic stem cells." Nature immunology. 2001 Jan; 2(1):11-2.
2000 Oct
Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL. "The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells." Leukemia.. 2000 Oct; 14(10):1777-84.
2000 Oct
Evans ME, Jordan CT, Chang SM, Conrad C, Gerberding JL, Kaufman HL, Mayhall CG, Nolta JA, Pilaro AM, Sullivan S, Weber DJ, Wivel NA. "Clinical infection control in gene therapy: a multidisciplinary conference." Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 2000 Oct; 21(10):659-73.
1999 Oct 1
Rosenzweig M, MacVittie TJ, Harper D, Hempel D, Glickman RL, Johnson RP, Farese AM, Whiting-Theobald N, Linton GF, Yamasaki G, Jordan CT, Malech HL. "Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning." Blood.. 1999 Oct 1; 94(7):2271-86.
1999 Oct
Howard DS, Rizzierri DA, Grimes B, Upchurch D, Phillips GL, Stewart AK, Yannelli JR, Jordan CT. "Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer." Leukemia.. 1999 Oct; 13(10):1608-16.
1999 Jul 20
Di Nicola M, Milanesi M, Magni M, Bregni M, Carlo-Stella C, Longoni P, Tomanin R, Ravagnani F, Scarpa M, Jordan C, Gianni AM. "Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes." Human gene therapy. 1999 Jul 20; 10(11):1875-84.
1999 Mar 16
Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM. "Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors." Proceedings of the National Academy of Sciences of the United States of America.. 1999 Mar 16; 96(6):2988-93.
1998 Apr
Bregni M, Shammah S, Malaffo F, Di Nicola M, Milanesi M, Magni M, Matteucci P, Ravagnani F, Jordan CT, Siena S, Gianni AM. "Adenovirus vectors for gene transduction into mobilized blood CD34+ cells." Gene therapy.. 1998 Apr; 5(4):465-72.
1998
Jordan CT, Van Zant G. "Recent progress in identifying genes regulating hematopoietic stem cell function and fate." Current opinion in cell biology. 1998 10(6):716-20.
1997 Apr
Harrison DE, Zhong RK, Jordan CT, Lemischka IR, Astle CM. "Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term." Experimental hematology.. 1997 Apr; 25(4):293-7.
1997
Orlic D, Girard LJ, Anderson SM, Do BK, Seidel NE, Jordan CT, Bodine DM. "Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels." Stem cells.. 1997 15 Suppl 1:23-8; discussion 28-9.
1996 Oct 1
Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM. "The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction." Proceedings of the National Academy of Sciences of the United States of America.. 1996 Oct 1; 93(20):11097-102.
1996 Sep
Jordan CT, Yamasaki G, Minamoto D. "High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations." Experimental hematology.. 1996 Sep; 24(11):1347-55.
1996 Aug 15
Neering SJ, Hardy SF, Minamoto D, Spratt SK, Jordan CT. "Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors." Blood.. 1996 Aug 15; 88(4):1147-55.
1995 Aug
Jordan CT, Astle CM, Zawadzki J, Mackarehtschian K, Lemischka IR, Harrison DE. "Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation." Experimental hematology.. 1995 Aug; 23(9):1011-5.
1994 Oct 15
Zeigler FC, Bennett BD, Jordan CT, Spencer SD, Baumhueter S, Carroll KJ, Hooley J, Bauer K, Matthews W. "Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells." Blood.. 1994 Oct 15; 84(8):2422-30.
1993 Feb
Harrison DE, Jordan CT, Zhong RK, Astle CM. "Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations." Experimental hematology.. 1993 Feb; 21(2):206-19.
1991 Oct 15
Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. "A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit." Proceedings of the National Academy of Sciences of the United States of America.. 1991 Oct 15; 88(20):9026-30.
1991 Jun 28
Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. "A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations." Cell.. 1991 Jun 28; 65(7):1143-52.
1990 Jun 15
Jordan CT, McKearn JP, Lemischka IR. "Cellular and developmental properties of fetal hematopoietic stem cells." Cell.. 1990 Jun 15; 61(6):953-63.
1990 Feb
Jordan CT, Lemischka IR. "Clonal and systemic analysis of long-term hematopoiesis in the mouse." Genes & development. 1990 Feb; 4(2):220-32.

Books

2002
Christopher Klug and Craig T. Jordan. Hematopoietic Stem Cell Protocols. Totowa, New Jersey: Humana Press, 2002.
2002
Srour, E.F., and Jordan, C.T.. "Isolation of viable cells based on their position in cell cycle.". Hematopoietic Stem Cell Protocols. Totowa, New Jersey: Humana Press, 2002.
1998
Jordan C.T., Howard, D.S., Zhao, S.F., Yannelli, J.R., and Grimes, B.. "Transduction of primitive hematopoietic cells with adenovirus-polycation gene transfer vehicles: New strategies for management of hematologic disease.". Autologous Blood and Marrow Transplantation, Proceedings of the Ninth Internati. : Carden Jennings Publishing., 1998.
1995
Jordan, C.T., and Van Zant, G.. "The Biology of Stem Cells.". The Biomedical Engineering Handbook. : CRC Press Inc., 1995.